Tag: Biontech
RIO DE JANEIRO, BRAZIL - The Brazilian ambassador to the European Union, Marcos Galvão, on Thursday, April 15th, advocated vaccination in the fight against the pandemic and asked for support from the European bloc to purchase more immunizers and...
RIO DE JANEIRO, BRAZIL - (BBC Brasil) Son of an Uruguayan woman, Abdel is an example of a 'doble chapa', as Brazilians of Uruguayan descent who have dual citizenship are called in the region.
Like him, Brazilians over 18 years...
RIO DE JANEIRO, BRAZIL - A study in Israel found that one of the coronavirus vaccines is effective against the British variant of the coronavirus, but has limitations with the South African variant. The finding was made by researchers...
RIO DE JANEIRO, BRAZIL - The maker of the West’s first Covid-19 vaccine is building a new manufacturing alliance that could throw Europe and the rest of the world a lifeline amid a painful shortage of shots and a...
RIO DE JANEIRO, BRAZIL - A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech vaccine by two-thirds, and it is not clear if the shot will be effective...
RIO DE JANEIRO, BRAZIL - On average, Chile has been immunizing more than 200,000 people a day since February 3rd, and expects to reach 2 million people vaccinated within the next 72 hours.
Even the deadlines that the government had...
RIO DE JANEIRO, BRAZIL - The race to find a vaccine against Covid-19 has transcended medical interest to also include a geopolitical focus, in which Russia and China, with their powerful public institutions, are competing with private pharmaceutical companies...
RIO DE JANEIRO, BRAZIL - Britain’s GlaxoSmithKline (GSK) and German biotech firm CureVac have teamed up in a 150 million euro deal to develop a COVID-19 vaccine next year that could target several variants with one shot.
New, more contagious...
RIO DE JANEIRO, BRAZIL - (Reuters) The Chilean health regulator has approved for emergency use the COVID-19 vaccine from Pfizer Inc and BioNTech SE, paving the way for the first doses to be administered as early as Christmas to...
